Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The purpose of this study was to develop a method of classifying cancers to specific diagnostic categories based on their gene expression signatures using artificial neural networks (ANNs). We trained the ANNs using the small, round blue-cell tumors (SRBCTs) as a model. These cancers belong to four distinct diagnostic categories and often present diagnostic dilemmas in clinical practice. The ANNs correctly classified all samples and identified the genes most relevant to the classification. Expression of several of these genes has been reported in SRBCTs, but most have not been associated with these cancers. To test the ability of the trained ANN models to recognize SRBCTs, we analyzed additional blinded samples that were not previously used for the training procedure, and correctly classified them in all cases. This study demonstrates the potential applications of these methods for tumor diagnosis and the identification of candidate targets for therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar techniques have been used to diagnose cancer by Khan et al, where the inputs are the PCs estimated from 6567 genes and the outcomes are the tumour categories.34”
From Artificial intelligence in healthcare: past, present and future (2017) · cites this paper as [34]
Citations
Cites
Neural networks for pattern recognition
(1994) · Choice Reviews Online · doi:10.5860/choice.31-5500 · Cited by 18,538
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261 · cited 1×
“Monitoring global gene-expression levels by cDNA microarrays provides an additional tool for elucidating tumor biology as well as the potential for molecular diagnostic classification of cance”
MethodCluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Neural Networks for Pattern Recognition
Bishop, C. M. (1995) · doi:10.1093/oso/9780198538493.001.0001 · Cited by 12,287
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 1×
“Once the models were calibrated they were used to rank the genes according to their importance for the classification (8).”
MethodDistinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925 · cited 1×
“This was repeated using each of the 3 groups for validation (6).”
MethodGoodall, C. (1988) · Technometrics · doi:10.1080/00401706.1988.10488412 · Cited by 8,675
Jolliffe, I. T. (1986) · Springer Series in Statistics · doi:10.1007/978-1-4757-1904-8 · Cited by 8,273
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Cited by
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Survey of Clustering Algorithms
Xu, R., & WunschII, D. (2005) · IEEE Transactions on Neural Networks · doi:10.1109/tnn.2005.845141 · Cited by 6,197
“and 5 non-SRBCT samples [164].”
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Artificial intelligence in healthcare: past, present and future
Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., & Wang, Y. (2017) · Stroke and Vascular Neurology · doi:10.1136/svn-2017-000101 · Cited by 4,837
mixOmics: An R package for ‘omics feature selection and multiple data integration
Rohart, F., Gautier, B., Singh, A., & Lê Cao, K.-A. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005752 · Cited by 4,056
“The study investigates Small Round Blue Cell Tumors (SRBCT, [35]) of 63 tumour samples with the expression levels of 2,308 genes.”
BackgroundMethodGene selection and classification of microarray data using random forest
Díaz-Uriarte, R., & Alvarez de Andrés, S. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-3 · Cited by 2,929
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R., Hastie, T., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,930
Methods for interpreting and understanding deep neural networks
Montavon, G., Samek, W., & Müller, K.-R. (2018) · Digital Signal Processing · doi:10.1016/j.dsp.2017.10.011 · Cited by 2,665
“Sensitivity analysis has been regularly used in scientific applications of machine learning such as medical diagnosis [29], ecological modeling [20], or mutagenicity prediction [6].”
BackgroundMethodBhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
What is principal component analysis?
Ringnér, M. (2008) · Nature Biotechnology · doi:10.1038/nbt0308-303 · Cited by 2,407
Self-citationNeuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211566398 · Cited by 2,023
Greenacre, M., Groenen, P. J. F., Hastie, T., D’Enza, A. I., Markos, A., & Tuzhilina, E. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00184-w · Cited by 1,773
Ali, S., Abuhmed, T., El-Sappagh, S., Muhammad, K., Alonso-Moral, J. M., Confalonieri, R., Guidotti, R., Del Ser, J., Díaz-Rodríguez, N., & Herrera, F. (2023) · Information Fusion · doi:10.1016/j.inffus.2023.101805 · Cited by 1,762
Support Vector Machines: Theory and Applications
(2005) · Studies in Fuzziness and Soft Computing · doi:10.1007/b95439 · Cited by 1,493
“Linear MLP neural network [21] 96 Nearest shrunken centroids [23] 43 Evolutionary algorithm [22] 12 SVM (linear or RBF kernel function) 7 SVM (polynomial kernel function, p = 2) 6”
BackgroundMethodInfluentialExplaining Deep Neural Networks and Beyond: A Review of Methods and Applications
Samek, W., Montavon, G., Lapuschkin, S., Anders, C. J., & Muller, K.-R. (2021) · Proceedings of the IEEE · doi:10.1109/jproc.2021.3060483 · Cited by 1,477
“measurement artifacts or adversarial perturbations [182]; 2) resilience to drifting data distributions [49]; 3) ability to accurately assess the confidence of its own predictions [135], [139]; 4) safety and security aspects [21], [26], [84], [193]; 5) legal requirements or adherence to social norms [54], [60]; 6) abil…”
BackgroundLê Cao, K.-A., Boitard, S., & Besse, P. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-253 · Cited by 1,007
“The Small Round Blue-Cell Tumor Data of childhood (SRBCT, [44]) includes 4 different types of tumors with 23, 20, 12 and 8 microarrays per class and 2308 genes.”
BackgroundPitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification
Simon, R., Radmacher, M. D., Dobbin, K., & McShane, L. M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.14 · Cited by 1,006
Kukurba, K. R., & Montgomery, S. B. (2015) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top084970 · Cited by 924
“Interestingly, in some cases, the sample heterogeneity can have advantages in transcriptome profiling by identifying novel pathways, implicating cellular origins of disease, or identifying previously unknown pathological sites (Alizadeh et al. 2000; Khan et al. 2001; Sorlie et al. 2001).”
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
Statnikov, A., Aliferis, C. F., Tsamardinos, I., Hardin, D., & Levy, S. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti033 · Cited by 839
“The SRBCT dataset was obtained by using two-color cDNA platform with consecutive image analysis performed by DeArray Software and filtering for a minimal level of expression (Khan et al., 2001).”
Efficient and Robust Feature Extraction by Maximum Margin Criterion
Li, H., Jiang, T., & Zhang, K. (2006) · IEEE Transactions on Neural Networks · doi:10.1109/tnn.2005.860852 · Cited by 841
“The authors would like to thank the associate editor and the anonymous reviewers for the constructive comments.”
BackgroundPrediction by Supervised Principal Components
Bair, E., Hastie, T., Paul, D., & Tibshirani, R. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000000628 · Cited by 817
Outcome signature genes in breast cancer: is there a unique set?
Ein-Dor, L., Kela, I., Getz, G., Givol, D., & Domany, E. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth469 · Cited by 802
Coexpression Analysis of Human Genes Across Many Microarray Data Sets
Lee, H. K., Hsu, A. K., Sajdak, J., Qin, J., & Pavlidis, P. (2004) · Genome Research · doi:10.1101/gr.1910904 · Cited by 770
“2001) 12 8243 2670 (Khan et al. 2001) 88 1952 19868 (Welsh et al.”
Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data
Bair, E., & Tibshirani, R. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020108 · Cited by 754
“…techniques that can be used to identify which subtype is present in a given patient (Golub et al. 1999; Hastie et al. 2001a; Hedenfalk et al. 2001; Khan et al. 2001; Ramaswamy et al. 2001; Nguyen and Rocke 2002a, 2002b; Shipp et al. 2002; Tibshirani et al. 2002; van de Vijver et al. 2002; van’t…”
BackgroundMethodLee, Y., Lin, Y., & Wahba, G. (2004) · Journal of the American Statistical Association · doi:10.1198/016214504000000098 · Cited by 741
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
Ein-Dor, L., Zuk, O., & Domany, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601231103 · Cited by 689
Molecular classification of human carcinomas by use of gene expression signatures.
Su, A. I., Welsh, J. B., Sapinoso, L. M., Kern, S. G., Dimitrov, P., Lapp, H., Schultz, P. G., Powell, S. M., Moskaluk, C. A., Frierson, H. F., et al. (2001) · PubMed · Cited by 688
Gruvberger-Saal, S. K., Ringnér, M., Chen, Y., Panavally, S., Saal, L. H., Borg, Å., Fernö, M., Peterson, C., & Meltzer, P. S. (2001) · PubMed · Cited by 673
Self-citationA review of microarray datasets and applied feature selection methods
Bolón-Canedo, V., Sánchez-Maroño, N., Alonso-Betanzos, A., Benítez, J. M., & Herrera, F. (2014) · Information Sciences · doi:10.1016/j.ins.2014.05.042 · Cited by 666
West, R. B., Corless, C. L., Chen, X., Rubin, B. P., Subramanian, S., Montgomery, K., Zhu, S., Ball, C. A., Nielsen, T. O., Patel, R., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63279-8 · Cited by 658
Li, T., Zhang, C., & Ogihara, M. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth267 · Cited by 648
“On the SRBCT, ALL, ALL/AML-4-class and ALL/AML-3-class datasets, the best accuracy is > 93%.”
InfluentialFrom Boolean to probabilistic Boolean networks as models of genetic regulatory networks
Shmulevich, I., Dougherty, E. R., & Zhang, W. (2002) · Proceedings of the IEEE · doi:10.1109/jproc.2002.804686 · Cited by 641
“For example, cancer classification using a variety of methods has been used to exploit the class-separating power of expression data: leukemias [6], various cancers [7], small, round, blue-cell cancers [8], and hereditary breast cancer [9].”
BackgroundSupervised, Unsupervised, and Semi-Supervised Feature Selection: A Review on Gene Selection
Ang, J. C., Mirzal, A., Haron, H., & Hamed, H. N. A. (2016) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2015.2478454 · Cited by 641
“2012b) [98] Null LDA technique & SRBCT [76]; NNC Sensitivity analysis; k-fold CV & Lung [68]; & Leukemia [66], [67];”
BackgroundMethodInfluentialVSURF: An R Package for Variable Selection Using Random Forests
Genuer, R., Poggi, J.-M., & Tuleau-Malot, C. (2015) · The R Journal · doi:10.32614/rj-2015-018 · Cited by 619
“These data, presented in details in Khan et al. (2001), available in the R package mixOmics , have been widely studied but in most cases only 200 genes were considered and data have been transformed to reduce the problem to a regression problem (see e.g. Lê Cao and Chabrier, 2008).”
MethodSoft tissue sarcomas of adults: state of the translational science.
Borden, E. C., Baker, L. H., Bell, R. S., Bramwell, V. H. C., Demetri, G. D., Eisenberg, B. L., Fletcher, C. D. �., Fletcher, J. A., Ladanyi, M., Meltzer, P. S., et al. (2003) · PubMed · Cited by 612
Self-citationClarke, R., Ressom, H. W., Wang, A., Xuan, J., Liu, M. C., Gehan, E. A., & Wang, Y. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2294 · Cited by 603
Adaptive Thresholding for Sparse Covariance Matrix Estimation
Cai, T., & Liu, W. (2011) · Journal of the American Statistical Association · doi:10.1198/jasa.2011.tm10560 · Cited by 590
“KEY WORDS: Frobenius norm; Optimal rate of convergence; Spectral norm; Support recovery; Universal thresholding.”
InfluentialCai, Y., Guan, K., Lobell, D., Potgieter, A. B., Wang, S., Peng, J., Xu, T., Asseng, S., Zhang, Y., You, L., et al. (2019) · Agricultural and Forest Meteorology · doi:10.1016/j.agrformet.2019.03.010 · Cited by 591
From patterns to pathways: gene expression data analysis comes of age
Slonim, D. K. (2002) · Nature Genetics · doi:10.1038/ng1033 · Cited by 572
BagBoosting for tumor classification with gene expression data
Dettling, M. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth447 · Cited by 542
Fibroblast growth factors and their receptors in cancer
Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 534
Sarcoma classification by DNA methylation profiling
Koelsche, C., Schrimpf, D., Stichel, D., Sill, M., Sahm, F., Reuss, D. E., Blattner, M., Worst, B., Heilig, C. E., Beck, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20603-4 · Cited by 532
Self-citationIizuka, N., Oka, M., Yamada-Okabe, H., Nishida, M., Maeda, Y., Mori, N., Takao, T., Tamesa, T., Tangoku, A., Tabuchi, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12775-4 · Cited by 511
Identifying distinct classes of bladder carcinoma using microarrays
Dyrskjøt, L., Thykjaer, T., Kruhøffer, M., Jensen, J. L., Marcussen, N., Hamilton-Dutoit, S., Wolf, H., & Ørntoft, T. F. (2003) · Nature Genetics · doi:10.1038/ng1061 · Cited by 501
Generalized Thresholding of Large Covariance Matrices
Rothman, A. J., Levina, E., & Zhu, J. (2009) · Journal of the American Statistical Association · doi:10.1198/jasa.2009.0101 · Cited by 489
Converting a breast cancer microarray signature into a high-throughput diagnostic test
Glas, A. M., Floore, A., Delahaye, L. J., Witteveen, A. T., Pover, R. C., Bakx, N., Lahti-Domenici, J. S., Bruinsma, T. J., Warmoes, M. O., Bernards, R., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-278 · Cited by 494
“Various studies have shown that microarray analysis results in improved diagnosis and risk stratification in many cancers [1-12].”
A robustness-based approach to systems-oriented drug design
Kitano, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2195 · Cited by 488
Discriminative Least Squares Regression for Multiclass Classification and Feature Selection
Xiang, S., Nie, F., Meng, G., Pan, C., & Zhang, C. (2012) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2012.2212721 · Cited by 473
“Each sample in this dataset contains 2308 gene expression values [54].”
BackgroundHudson, D. L. (2006) · Wiley Encyclopedia of Biomedical Engineering · doi:10.1002/9780471740360.ebs0901 · Cited by 465
Saal, L. H., Troein, C., Vallon-Christersson, J., Gruvberger, S., Borg, Å., & Peterson, C. (2002) · Genome Biology · doi:10.1186/gb-2002-3-8-software0003 · Cited by 462
“Whereas microarrays have shed light on many biological processes and disease states, for us [7-10] and others, a significant bottleneck remains the analysis of hybridization data in the context of biomaterial and reporter annotations.”
BackgroundSelf-citationJoint covariate selection and joint subspace selection for multiple classification problems
Obozinski, G., Taskar, B., & Jordan, M. I. (2010) · Statistics and Computing · doi:10.1007/s11222-008-9111-x · Cited by 451
“6, consider a DNA microarray analysis problem in which the covariates are levels of gene expression and the responses are phenotypes or cellular processes (Khan et al. 2001).”
BackgroundLowery, A. J., Miller, N., Devaney, A., McNeill, R. E., Davoren, P. A., Lemetre, C., Benes, V., Schmidt, S., Blake, J., Ball, G., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2257 · Cited by 450
“The models produced by ANNs have been shown to have the ability to predict well for unseen data and have the ability to cope with complexity and nonlinearity within the dataset [20,21]; these features of ANNs means they have the potential to identify and model patterns in this type of data to address a particular ques…”
Wang, M., Chen, H., Yang, B., Zhao, X., Hu, L., Cai, Z., Huang, H., & Tong, C. (2017) · Neurocomputing · doi:10.1016/j.neucom.2017.04.060 · Cited by 450
“[42] proposed a method for the diagnostic prediction of cancers based on gene expression profiling and artificial neural networks.”
MethodClustering cancer gene expression data: a comparative study
de Souto, M. C., Costa, I. G., de Araujo, D. S., Ludermir, T. B., & Schliep, A. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-497 · Cited by 444
Wrapper–Filter Feature Selection Algorithm Using a Memetic Framework
Zhu, Z., Ong, Y.-S., & Dash, M. (2007) · IEEE Transactions on Systems, Man and Cybernetics, Part B (Cybernetics) · doi:10.1109/tsmcb.2006.883267 · Cited by 443
“In particular, we focus on four UCI data sets having more than 15 features and four microarray data sets (i.e., ALL/AML [25], Colon [26], NCI60 [27], and SRBCT [28]) having thousands of features in our study.”
Filter versus wrapper gene selection approaches in DNA microarray domains
Inza, I., Larrañaga, P., Blanco, R., & Cerrolaza, A. J. (2004) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2004.01.007 · Cited by 425
“Apart from the FSS approach, other dimensionality reduction procedures appear in supervised microarray literature such as principal component analysis [49] or partial least square [50].”
MethodPérez‐Enciso, M., & Tenenhaus, M. (2003) · PubMed · doi:10.1007/s00439-003-0921-9 · Cited by 421
Ultrahigh dimensional variable selection: beyond the linear model
Fan, J., Samworth, R. J., & Wu, Y. (2008) · PubMed · doi:10.48550/arxiv.0812.3201 · Cited by 521
“In this section, we apply our method to the children cancer data set reported in Khan et al. (2001). Khan et al.”
InfluentialMolecular portraits of breast cancer: tumour subtypes as distinct disease entities
Sørlie, T. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.021 · Cited by 415
Class Prediction by Nearest Shrunken Centroids, with Applications to DNA Microarrays
Tibshirani, R., Hastie, T., Narasimhan, B., & Chu, G. (2003) · Statistical Science · doi:10.1214/ss/1056397488 · Cited by 410
“Recent proposals for this problem include Golub et al. (1999), Hedenfalk et al. (2001), Hastie, Tibshirani, Botstein and Brown (2001) and the artificial neural network approach in Khan et al. (2001).”
BackgroundSimple decision rules for classifying human cancers from gene expression profiles
Tan, A. C., Naiman, D. Q., Xu, L., Winslow, R. L., & Geman, D. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti631 · Cited by 402
“, 2002) SRBCT cDNA 4 2,308 63 20 (Khan et al., 2001) Breast Affy 5 9,216 54 30 (Perou et al.”
An extensive comparison of recent classification tools applied to microarray data
Lee, J. W., Lee, J. B., Park, M., & Song, S. H. (2005) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2004.03.017 · Cited by 395
“Small round blue cell tumor (SRBCT) This dataset comes from SRBCT study of childhood (Khan et al., 2001).”
BackgroundNeural networks: An overview of early research, current frameworks and new challenges
Prieto, A., Prieto, B., Ortigosa, E. M., Ros, E., Pelayo, F., Ortega, J., & Rojas, I. (2016) · Neurocomputing · doi:10.1016/j.neucom.2016.06.014 · Cited by 391
Roadmap for Developing and Validating Therapeutically Relevant Genomic Classifiers
Simon, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8712 · Cited by 382
DNA Microarrays in Clinical Oncology
Ramaswamy, S., & Golub, T. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.7.1932 · Cited by 379
Classification of gene microarrays by penalized logistic regression
Zhu, J. (2004) · Biostatistics · doi:10.1093/biostatistics/5.3.427 · Cited by 372
“See Golub et al. (1999), Khan et al. (2001), Lee and Lee (2002), Ramaswamy et al. (2001), Tibshirani et al. (2002) and references therein for recent work.”
BackgroundLee, Y., & Lee, C.-K. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg102 · Cited by 367
“See Golub et al. (1999), Mukherjee et al. (1999), Dudoit et al. (2000), Furey et al. (2000), Khan et al. (2001), Yeo and Poggio (2001), and references therein.”
InfluentialMissiaglia, E., Williamson, D., Chisholm, J., Wirapati, P., Pierron, G., Petel, F., Concordet, J.-P., Thway, K., Oberlin, O., Pritchard-Jones, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5591 · Cited by 365
Current progress and open challenges for applying deep learning across the biosciences
Sapoval, N., Aghazadeh, A., Nute, M. G., Antunes, D. A., Balaji, A., Baraniuk, R., Barberan, C. J., Dannenfelser, R., Dun, C., Edrisi, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29268-7 · Cited by 359
Osteosarcoma Development and Stem Cell Differentiation
Tang, N., Song, W.-X., Luo, J., Haydon, R. C., & He, T.-C. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0335-z · Cited by 357
Classifying Gene Expression Profiles from Pairwise mRNA Comparisons
Geman, D., d'Avignon, C., Naiman, D. Q., & Winslow, R. L. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1071 · Cited by 354
Gene expression profiling of human sarcomas: insights into sarcoma biology.
Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1699 · Cited by 353
Self-citationExpression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Smith, R., Owen, L. A., Trem, D. J., Wong, J. S., Whangbo, J. S., Golub, T. R., & Lessnick, S. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.004 · Cited by 351
“…for transformation, we knocked down EWS/FLI with the EF-2-RNAi retrovirus and The complete gene expression data from Figure 4A (stable knockdown) and Figure 4B (inducible rescue) were rank ordered, as described in the text, and compared to data from small round blue cell tumors (Khan et al., 2001).”
MethodResultInfluentialGene selection: a Bayesian variable selection approach
Lee, K. E., Sha, N., Dougherty, E. R., Vannucci, M., & Mallick, B. K. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.1.90 · Cited by 352
“Even in studies that obtained smaller numbers of genes, the numbers are excessive for the small number of sample points (microarrays), for instance 50 genes (Golub et al., 1999) or 96 genes (Khan et al., 2001).”
BackgroundMolecular Staging for Survival Prediction of Colorectal Cancer Patients
Eschrich, S., Yang, I., Bloom, G., Kwong, K. Y., Boulware, D., Cantor, A., Coppola, D., Kruhøffer, M., Aaltonen, L., Orntoft, T. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.695 · Cited by 348
Tumor origin detection with tissue-specific miRNA and DNA methylation markers
Tang, W., Wan, S., Yang, Z., Teschendorff, A. E., & Zou, Q. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx622 · Cited by 347
Unsupervised Feature Selection with Structured Graph Optimization
Nie, F., Zhu, W., & Li, X. (2016) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v30i1.10168 · Cited by 321
“SRBCT (Khan et al. 2001), Lung (Singh et al.”
BackgroundDai, J., & Xu, Q. (2013) · Applied Soft Computing · doi:10.1016/j.asoc.2012.07.029 · Cited by 344
Barshan, E., Ghodsi, A., Azimifar, Z., & Zolghadri Jahromi, M. (2011) · Pattern Recognition · doi:10.1016/j.patcog.2010.12.015 · Cited by 343
“We perform experiments on three data sets: Colon Cancer [32], Lymphoma [33], and SRBCT [34]; their descriptions are presented in Table 1.”
MethodIterative RELIEF for Feature Weighting: Algorithms, Theories, and Applications
Sun, Y. (2007) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2007.1093 · Cited by 342
“The second test-bed contains six microarray datasets: 9-tumors [29], Brain-tumor2 [30], Leukemia-1 [2], prostate-tumors [31], DLBCL [32] and SRBCT [33].”
BackgroundProtein tyrosine phosphatases as potential therapeutic targets
He, R.-J., Yu, Z.-H., Zhang, R.-Y., & Zhang, Z.-Y. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.80 · Cited by 327
Chen, C., & Gu, G. X. (2020) · Advanced Science · doi:10.1002/advs.201902607 · Cited by 335
Fundamentals of cDNA microarray data analysis
Leung, Y. F., & Cavalieri, D. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.09.015 · Cited by 331
Predictive non-linear modeling of complex data by artificial neural networks
Almeida, J. S. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00288-4 · Cited by 330
Somorjai, R. L., Dolenko, B., & Baumgartner, R. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg182 · Cited by 332
“We present results obtained for two publicly available microarray datasets: the two-class leukemia set (Golub et al., 1999), and the four-class small, round blue-cell tumor (SRBCT) set (Khan et al., 2001; Yeo and Poggio, 2001).”
BackgroundMethodInfluentialNeuroblastoma: biology and molecular and chromosomal pathology
Schwab, M., Westermann, F., Hero, B., & Berthold, F. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01166-5 · Cited by 325
Self-citationVI, J. G. T., Cheuk, A. T., Tsang, P. S., Chung, J.-Y., Song, Y. K., Desai, K., Yu, Y., Chen, Q.-R., Shah, K., Youngblood, V., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39703 · Cited by 321
Self-citationFeature selection for high-dimensional class-imbalanced data sets using Support Vector Machines
Maldonado, S., Weber, R., & Famili, F. (2014) · Information Sciences · doi:10.1016/j.ins.2014.07.015 · Cited by 317
“SRBCT data set: The SRBCT data set contains 83 samples in four classes: Ewing family of tumors, Burkitt lymphoma, neuroblastoma, and rhabdomyosarcoma [19, 47].”
MethodRobustness of Random Forest-based gene selection methods
Kursa, M. B. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-8 · Cited by 315
Artificial neural networks enabled by nanophotonics
Zhang, Q., Yu, H., Barbiero, M., Wang, B., & Gu, M. (2019) · Light: Science & Applications · doi:10.1038/s41377-019-0151-0 · Cited by 317
Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
Haugsten, E. M., Wiedlocha, A., Olsnes, S., & Wesche, J. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0168 · Cited by 315
“In addition, FGFR4 is often highly expressed in RMS and FGFR4 expression correlates with advanced stage and poor survival (37, 106, 107).”
BackgroundWeighted k-Nearest-Neighbor Techniques and Ordinal Classification
Hechenbichler, K., & Schliep, K. P. (2004) · Econstor (Econstor) · doi:10.5282/ubm/epub.1769 · Cited by 307
“The SRBCT dataset is presented in Kahn et al. (2001) and contains expression values of 2308 genes for 83 Single Round Blue Cells Tumor patients, each coming from one out of 4 different classes (EWS, BL, NB and RMS).”
MethodGene selection with guided regularized random forest
Deng, H., & Runger, G. (2013) · Pattern Recognition · doi:10.1016/j.patcog.2013.05.018 · Cited by 304
“class [28] 95 4869 3 colon [2] 62 2000 2 leukemia [9] 38 3051 2 lymphoma [1] 62 4026 3 nci60 [21] 61 5244 8 prostate [24] 102 6033 2 srbct [16] 63 2308 4”
Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
Davicioni, E., Anderson, M. J., Finckenstein, F. G., Lynch, J. C., Qualman, S. J., Shimada, H., Schofield, D. E., Buckley, J. D., Meyer, W. H., Sorensen, P. H. B., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080631 · Cited by 297
“Several important conclusions emerge from our analysis of RMS, which represents the largest gene expression profiling study performed to date for this disease.(28,36) We find that homogeneous and reproducible subtypes of RMS, as reflected in gene expression profiles, are at odds with the International Classification o…”
MethodAdvantages and limitations of microarray technology in human cancer
Russo, G., Zegar, C., & Giordano, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206865 · Cited by 289
“Khan et al. (2001) were able to correctly classify the four types of small round blue-cell tumors of childhood cancer samples, analysing the gene expression patterns of 83 samples and artificial neural networks.”
BackgroundAccurate Cancer Classification Using Expressions of Very Few Genes
Wang, L., Chu, F., & Xie, W. (2007) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2007.1006 · Cited by 290
“There are, in total, 63 training samples and 25 testing samples already provided in [2]; five of the testing samples are not SRBCTs.”
BackgroundMethodResultInfluentialKernel Methods and Machine Learning
Kung, S. Y. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139176224 · Cited by 287
“5 shows a threelevel hierarchy constructed by VISDA to fully explore the four-cluster data structure in the NCI-SRBCT dataset [123].”
BackgroundMethodPaweletz, C. P., Trock, B., Pennanen, M., Tsangaris, T., Magnant, C., Liotta, L. A., & Petricoin, E. F. (2001) · Disease Markers · doi:10.1155/2001/674959 · Cited by 285
Metadata
- Authors
- Khan, J., Wei, J. S., Ringnér, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., & Meltzer, P. S.
- Affiliations
- National Institutes of Health (US)
- Memorial Sloan Kettering Cancer Center (US)
- German Cancer Research Center (DE)
- University of Cologne (DE)
- Lund University (SE)
- Corresponding author
- Khan, Javed
- Meltzer, Paul S.
- ORCID
- Venue
- Nature Medicine
- Published
- 2001-06
- Volume
- 7
- Issue
- 6
- Pages
- 673-679
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC1282521
- OpenAlex
- W1727290854
- Cited by
- 2,644
- References
- 46
- Citations by year
- 2026: 24 · 2025: 42 · 2024: 47 · 2023: 84 · 2022: 82 · 2021: 84 · 2020: 112 · 2019: 123 · 2018: 83 · 2017: 93 · 2016: 92 · 2015: 96 · 2014: 126 · 2013: 98 · 2012: 109
- FWCI
- 47.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Cancer Institute (Z01SC010366)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Keywords
- cancer classification, gene expression profiling, artificial neural networks, small round cell tumor, diagnostic prediction, tumor diagnosis, gene expression signatures, drug target identification
- MeSH terms
- Burkitt Lymphoma, Data Interpretation, Statistical, Humans, Models, Biological, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Tumor Cells, Cultured, Neural Networks, Computer, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.